Latest news
Loading news…
PAREXEL
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Medium growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Waltham, Massachusetts, United States Founded 1983 10001+ employees For Profit
PAREXEL is a biopharmaceutical services company that focuses on the development and commercialization of new medical therapies worldwide.
PAREXEL was acquired by EQT in 2021 for $9B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
21
Monthly Visits
Available in Pro Contacts
9,893
Patents
7
14 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- PRXL
- Exchange
- NASDAQ
- IPO date
- Dec 1, 1995
- Delisted
- Sep 29, 2017
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 63
- Mobile apps
- 9
- Downloads (30d)
- 31
- Active products
- 37
- Patents granted
- 7
- Trademarks
- 14
- Top patent class
- Computing; Calculating
- IT spend
- $292M
Company Info
- Founded
- 1983
- Employees
- 10001+
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- Sub-organizations
- 6
- News articles
- 293
- Events
- 5
- HQ
- Waltham, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Dec 1, 1995
Signals & Scores
- Heat score
- High
- Growth score
- Medium
- Trend (7d)
- -0.2
- Trend (30d)
- 3.1
- Trend (90d)
- 4.5
- Last leadership hire
- Aug 21, 2025
Acquisitions by PAREXEL
Loading columns…
0 of 0Show
Page 1 / 1
Key People at PAREXEL
Chief Operating & Growth Officer
Senior Consultant
Chief Medical Officer and Global Head, Oncology Center of Excellence
SVP and Global Head Real World Research
Corporate VP and Controller
Director, University Relations- Talent Aquisition
Vice President, GDO Innovation Lead and GDO India Head
President of Global Clinical and Data Operations
Principal Enterprise Architect
CEO
Senior Vice President, Clinical Research
SVP, Global Head of Immunology and Inflammation
CBO
Senior Project Lead EPD
Senior Manager, Regulatory Affairs
Executive Vice President and Chief Financial Officer
9,893
professional contacts at PAREXEL
Contact execs at PAREXEL →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to PAREXEL
Loading news…
FAQs about PAREXEL
People who checked this page also checked these
Sectors PAREXEL invests & acquires in
Browse the full Acquirezy directory.